This article provides a comprehensive guide for researchers and drug development professionals seeking to enhance the sensitivity of pathogen detection assays.
Accurate bacterial genome identification is fundamental to clinical diagnostics, drug development, and public health, but its reliability is critically dependent on the reference databases used.
The viable but non-culturable (VBNC) state is a survival strategy adopted by numerous bacterial pathogens, allowing them to evade conventional culture-based detection, thereby posing a significant threat to food safety...
Cultivating fastidious bacteria remains a significant challenge in clinical microbiology and drug development, often hindering pathogen identification, antibiotic susceptibility testing, and biomedical research.
This article explores the transformative convergence of advanced microscopy, microfluidics, and artificial intelligence in bacterial detection and identification.
This article provides a comprehensive overview of molecular fingerprinting and its pivotal role in characterizing novel bacterial strains and combating antibiotic resistance.
This article provides a comprehensive overview of the polyphasic taxonomic approach, which integrates phenotypic, genotypic, and phylogenetic data for robust bacterial identification and classification.
Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) has revolutionized clinical microbiology, yet significant challenges persist in its application for identifying novel and closely related bacterial species.
The landscape of human bacterial pathogens is undergoing a rapid and critical expansion, driven by genomic plasticity, antimicrobial resistance (AMR), and a deeper understanding of pathogenicity mechanisms.
This article synthesizes current research on the discovery, clinical impact, and management of novel bacterial taxa in immunocompromised patients.